Avid Bioservices Inc (CDMO)

[biopharm]

David Carbone : Peregrine Pharmaceuticals KOL :

You just don't know what will come of Tustin that gets the ball rolling. All I see though are Peregrine KOL's spreading the word and it looks like we needed an Ebola nightmore to get the balling on that end and what will it take next?? ... just because manufacturing doubled in size, maybe larger single-use bioreactors and efficient planning, it will result in 3x the production... not just double. Hopefully an analyst will take care of that question on the conference call.

Now back to mans best friend... living longer

------------------------------

Ohio State University Faculty member awarded grant through National Canine Cancer Foundation

Dr. Gwendolen Lorch, assistant professor in the Department of Veterinary Clinical Sciences, was featured in a Columbus CEO article about pets with allergy symptoms.

The story, “Pet allergies are big business,” explains how there are very few vaccines or treatment options for pets with allergies. One problem is that the diagnostics take time and money, just like human medicine. There seems to be more pets that experience allergy symptoms in the Midwest, Lorch said.

According to the article, the most common canine breeds with a predisposition for allergies are Labradors, Golden Retrievers, German Shepherds, Pit Bulls, Golden Doodles, Pugs, Bulldogs and Boston Terriers. Flea Allergic Dermatitis is the most prevelant allergy among both cats and dogs, affecting the skin.

Not only is Lorch working with dogs that have allergies, she’s also in the process of helping those with lung cancer. She is the first veterinarian from Ohio to be awarded a grant from the National Canine Cancer Foundation.

She is utilizing the $97,000 grant in her research, which focuses on targeting heat shock proteins in canine lung cancer. She’s collaborating with Dr. David Carbone, thoracic oncology specialist at The James Cancer Hospital.

Article source:
https://vet.osu.edu/cvm/faculty-member-awarded-grant-through-national-canine-cancer-foundation-featured-columbus-ceo

http://www.wearethecure.org/blog/ohio-state-university-faculty-member-awarded-grant-through-national-canine-cancer-foundation/

HSP = Heat Shock Protein post that stands out below and mans best friend and all animals would benefit greatly with PS Targeting. Heck, the FDA even has like hardly no regulations for animal trials and approvals. You telling me that "Bravecto" gets FDA approval and knowing that flipped-PS exists on all dog lung cancers ... how hard will it be to get Bavi/PS Targeting FDA approved for this condition?? Oh hold... thats right, concentrate on late 2016 and early 2017 lol

we showed that Hsp70 and Hsc70 display a highly selective interaction with phosphatidylserine moieties on membranes,

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110833861